A kind of antithrombin Ⅲ assay kit and its detection method
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A technology of antithrombin and reagent kits, applied in the field of biomedical testing, can solve problems such as large application limitations, complicated operation, and poor stability, and achieve the effects of strong anti-interference ability, wide application prospects, and good stability
Active Publication Date: 2020-06-19
NINGBO RUI BIO TECH
View PDF9 Cites 0 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
[0005] However, the chromogenic substrate method also has certain defects. This method is to analyze the AT-III activity in the sample by adding exogenous thrombin, because there is also another heparin-catalyzed thrombin inhibitor—heparin cofactor II in the sample. (HCII), so the activity of determining the remaining thrombin is the remaining activity of thrombin after reacting with AT-III and HCII, therefore, this method is susceptible to the interference of HCII in the sample, resulting in inaccurate determination of AT-III
[0006] Currently commercially available reagents mainly use heparinase to degrade heparin to reduce the interference of HCII, but the operation is complicated and the heparinase is expensive, which greatly increases the cost
The other is through the coagulation factor Xa pathway. Although it avoids the interference of heparin cofactor II, the coagulation factor Xa is not only expensive, but also has poor stability. The sensitivity of the reagent is not as high as that of the thrombin pathway, and its application is very limited.
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0039] The antithrombin III assay kit of this embodiment consists of the following components:
[0056] Sodium azide 1g / L, HD-Phe-Pip-Arg-pNA·2HCl 2g / L.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention belongs to the technical field of biomedical examination, and relates to an antithrombin III determination kit and a detection method thereof. The kit comprises a reagent R1 and a reagent R2, wherein the reagent R1 comprises a buffer solution, a stabilizer, a salt, a surfactant, a preservative, trehalose, heparin and thrombin; and the reagent R2 comprises the buffer solution, the stabilizer, the surfactant, the preservative and a chromogenic substrate. A sample and deionized water are mixed according to a volume ratio of 1:(3-5) to obtain a diluted sample; and the diluted sampleis incubated for 30-60 s, the reagent R1 is added, uniform mixing and incubation are carried out for 60-100 s, the reagent R2 is added, uniform mixing is carried out, and then the obtained mixture isdetected at a wavelength of 405 nm.
Description
technical field [0001] The invention belongs to the technical field of biomedical testing, and relates to an antithrombin III assay kit and a detection method thereof. Background technique [0002] Antithrombin Ⅲ (AT-Ⅲ) is a single-chain glycoprotein, which belongs to α2 globulin. AT-Ⅲ has the function of decomposing lipoproteins and inhibits almost all active serine proteases in the coagulation system. AT-III, as the most important inhibitor of active coagulation factors in blood, controls blood coagulation and fibrin dissolution. The level of antithrombin III in the blood varies depending on various diseases and symptoms. Reduced in disseminated intravascular coagulation (DIC), liver disease, nephrotic syndrome, etc. Decreased levels of antithrombin III in the blood may prevent the effect of heparin therapy. Therefore, it is of great significance to know the activity of antithrombin III as an index for the monitoring, pathological analysis, prognosis judgment and hepari...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more